Case Study: Individualizing Medication Recommendations Using Pharmacogenomic Test Results |
JB is an 81-year-old female PACE participant with a past medical history of allergic rhinitis, anxiety, chronic back pain, chronic kidney disease (CKD) stage 3, coronary artery disease (CAD), dementia with behavioral disturbances, gastroesophageal reflex disease (GERD), hyperlipidemia (HLD), major depressive disorder (MDD), neuropathy, and osteoporosis. She has been admitted to the emergency room multiple times in the past six months due to increased aggressive behaviors with staff and other participants at the PACE center. |
|
The Case for Pharmacogenomic Testing for All PACE Participants |
Since 2013, CareKinesis has been providing PACE client organizations with optional pharmacogenomic (PGx) testing to support participants medication safety for those on certain pro-drug medications or when a long list of ‘allergies’ to medications were noted. However, in June 2015, a lawsuit was filed by the state of Hawaii against the two large drug companies who marketed clopidogrel (Plavix), which is an antiplatelet agent frequently initiated with the placement of coronary artery stents. On February 15, 2021, the court ordered the drug companies to pay more than $834 million to the state for misleading practices for failing to warn a subset of patients of health risks from Plavix.
In light of these lawsuits, and several pending in other states, we are taking the opportunity to consider personalizing medication regimens for all PACE participants prospectively.
|
|
CareKinesis Celebrates 10 Years of Success in PACE |
|
CareKinesis is excited to celebrate 10 years of partnering with PACE organizations. CareKinesis is the first national PACE-centric medication management and distribution pharmacy and was founded in 2009 by TRHC Chairman and CEO, Calvin H. Knowlton, PhD, and President Orsula V. Knowlton, PharmD. In 2011, CareKinesis partnered with its first PACE clients, LIFE St. Francis and Trinity Health LIFE (formerly LIFE at Lourdes) in New Jersey. Both clients remain valued partners, and CareKinesis maintains a national partnership with Trinity Health PACE at 20 centers in nine states.
This year-long anniversary celebration will highlight the history of CareKinesis and will include various commemorative activities, such as a special event coinciding with the National PACE Association (NPA’s) annual conference in October. Event updates will be communicated in future editions of the President’s Letter, The PACE Monthly Dose eNewsletter, the CVHC eNewsletter, and email communications. Join us in celebrating 10 years of excellence and service to PACE!
|
|
Coming Soon: Voice/Text Delivery Notifications |
|
CareKinesis will soon provide information about medication deliveries via voice and text messages to PACE participants or their designated caregivers who opt in for the service. Notifications about medication delivery and tracking will be sent from CareKinesis Pharmacy’s telephone number so that participants know who is calling and how to contact us. To learn more, contact your CareKinesis client liaison, email info@carekinesis.com, or call 888-974-2763. |
|
Introducing Tabula Rasa HealthCare's T21 Experiences |
|
Because of our inability to visit with you during the pandemic, we created an exciting virtual opportunity to let you know that you are still very much on our minds!
We would like to extend an exclusive and limited invitation to our upcoming event on April 20, 2021, from 1:00 p.m. to 2:00 p.m. ET with one of the hottest photographers in today’s music scene, Danny Clinch!
Danny will take us through the stories behind his photography work with Johnny Cash, Tupac, Bruce Springsteen, the Rolling Stones, Vanity Fair, and more! You will also get an opportunity to participate in a live, interactive conversation with Danny.
|
|
Use the password: T21E.
If you have any questions, please feel free to reach out to Donna Litten at DLitten@TRHC.com. |
|
Session #4: COVID-19 Simulation Studies and Outcomes
Wednesday, April 21, 2021
12 p.m. EDT
This webinar will discuss the risk of adverse drug events associated with drugs repurposed for the treatment of COVID-19 in older adults on multiple medications.
Presenters:
- Veronique Michaud, BPharm, MSc, PhD, Chief Operating Officer, Tabula Rasa HealthCare (TRHC) Precision Pharmacotherapy Research & Development Institute
- Matt Smith, PhD, Research Data Scientist, TRHC Pharmacotherapy Research & Development Institute
The CareKinesis Medication Safety Science Webinar Series covers multiple topics in short 30-minute sessions presented every two weeks. Watch your email inbox for invitations to upcoming sessions. Registrants who attend all webinars in the series will have a chance to win a pair of Apple AirPods Pro.
|
Webinars and Educational Offerings |
CareKinesis offers live CE-accredited webinars through Tabula Rasa HealthCare University (TRHCU). Non-CE-accredited Clinical Advisory Panel (CAP) 2020 modules are also available on demand. New offerings for 2021 include MedWiseTM introduction sessions and COVID-19 immunization webinars.
April
-
20 - T21 Experience featuring Danny Clinch
-
21 - COVID-19 Simulation Studies and Outcomes*
*CareKinesis Medication Safety Science Webinar Series
For more information, contact your CareKinesis Client Liaison.
|
|
|
|
|
|
|
